Results
1170
Companies which are more than 50% undervalued based on analyst price target.
1170 companies
JD.com
Market Cap: US$47.1b
Operates as a supply chain-based technology and service provider in the People’s Republic of China.
JD
US$32.70
7D
0.4%
1Y
25.3%
Summit Therapeutics
Market Cap: US$15.8b
A biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies.
SMMT
US$21.20
7D
1.3%
1Y
181.2%
QXO
Market Cap: US$14.4b
Distributes roofing, waterproofing, and other building products in the United States.
QXO
US$21.18
7D
-9.9%
1Y
-67.8%
Moderna
Market Cap: US$10.7b
A biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally.
MRNA
US$28.69
7D
7.1%
1Y
-75.5%
BioMarin Pharmaceutical
Market Cap: US$10.5b
A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.
BMRN
US$56.19
7D
2.7%
1Y
-31.7%
Aurora Innovation
Market Cap: US$9.3b
Operates as a self-driving technology company in the United States.
AUR
US$5.05
7D
-7.3%
1Y
76.0%
VinFast Auto
Market Cap: US$8.3b
Engages in the design and manufacture of electric vehicles (EV), e-scooters, and e-buses in Vietnam, Canada, and the United States.
VFS
US$3.56
7D
1.4%
1Y
-15.2%
Corcept Therapeutics
Market Cap: US$7.8b
Engages in discovery and development of medication for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.
CORT
US$69.31
7D
-9.7%
1Y
119.6%
Roivant Sciences
Market Cap: US$7.7b
A clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines and technologies.
ROIV
US$10.94
7D
-5.2%
1Y
3.6%
Revolution Medicines
Market Cap: US$6.9b
A clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers.
RVMD
US$36.89
7D
-7.8%
1Y
-1.3%
Legend Biotech
Market Cap: US$6.5b
Through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe.
LEGN
US$36.29
7D
5.8%
1Y
-18.9%
ZEEKR Intelligent Technology Holding
Market Cap: US$6.5b
An investment holding company, engages in the research and development, production, commercialization, and sale of the electric vehicles and batteries.
ZK
US$25.64
7D
-3.2%
1Y
42.4%
Jazz Pharmaceuticals
Market Cap: US$6.4b
Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.
JAZZ
US$109.44
7D
1.2%
1Y
4.1%
Lantheus Holdings
Market Cap: US$5.7b
Develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in diagnosis and treatment of heart, cancer, and other diseases worldwide.
LNTH
US$79.42
7D
-1.9%
1Y
1.2%
Nuvalent
Market Cap: US$5.5b
A clinical-stage biopharmaceutical company, engages in the development of therapies for patients with cancer.
NUVL
US$78.01
7D
1.5%
1Y
6.9%
Axsome Therapeutics
Market Cap: US$5.2b
A biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States.
AXSM
US$102.97
7D
-1.2%
1Y
30.5%
Chagee Holdings
Market Cap: US$4.8b
Through its subsidiaries, owns, operates, and franchises teahouses under the CHAGEE brand name in the People’s Republic of China and internationally.
CHA
US$26.20
7D
-6.9%
1Y
n/a
ChampionX
Market Cap: US$4.8b
Provides chemistry solutions, artificial lift systems, and engineered equipment and technologies to oil and gas companies worldwide.
CHX
US$25.92
7D
5.1%
1Y
-21.5%
Pony AI
Market Cap: US$4.7b
Through its subsidiaries, engages in the autonomous mobility business in the People’s Republic of China, the United States, and internationally.
PONY
US$13.20
7D
-0.5%
1Y
n/a
CRISPR Therapeutics
Market Cap: US$4.5b
A gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform.
CRSP
US$48.51
7D
3.7%
1Y
-8.7%
ADMA Biologics
Market Cap: US$4.3b
A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.
ADMA
US$17.88
7D
0.2%
1Y
56.8%
Vaxcyte
Market Cap: US$4.2b
A clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases.
PCVX
US$32.94
7D
-3.4%
1Y
-56.7%
Cytokinetics
Market Cap: US$3.9b
A late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases in the United States.
CYTK
US$33.64
7D
0.7%
1Y
-38.7%
Merus
Market Cap: US$3.9b
A clinical-stage immuno-oncology company, engages in the development of antibody therapeutics in the Netherlands.
MRUS
US$52.66
7D
-2.7%
1Y
-0.8%
Zai Lab
Market Cap: US$3.9b
A biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases.
ZLAB
US$35.17
7D
-6.4%
1Y
102.5%
Cellebrite DI
Market Cap: US$3.8b
Develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific.
CLBT
US$15.81
7D
-2.8%
1Y
30.4%
Inspire Medical Systems
Market Cap: US$3.8b
A medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally.
INSP
US$130.81
7D
-1.3%
1Y
-2.6%
Remitly Global
Market Cap: US$3.8b
Engages in the provision of digital financial services in the United States, Canada, and internationally.
RELY
US$18.46
7D
-9.3%
1Y
48.3%
Core Natural Resources
Market Cap: US$3.7b
Produces, sells, and exports metallurgical and thermal coals in the United States and internationally.
CNR
US$65.27
7D
-4.2%
1Y
-36.8%
Zeta Global Holdings
Market Cap: US$3.6b
Operates an omnichannel data-driven cloud platform that provides enterprises with consumer intelligence and marketing automation software in the United States and internationally.
ZETA
US$15.14
7D
-6.1%
1Y
-13.2%
Arcellx
Market Cap: US$3.6b
Together with its subsidiary, engages in the development of various immunotherapies for patients with cancer and other incurable diseases in the United States.
ACLX
US$64.69
7D
2.1%
1Y
21.5%
Ultragenyx Pharmaceutical
Market Cap: US$3.4b
A biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Latin America, Europe, the Middle East, Africa, and the Asia-Pacific.
RARE
US$36.26
7D
-2.4%
1Y
-11.5%
Avidity Biosciences
Market Cap: US$3.4b
A biopharmaceutical company, engages in the delivery of RNA therapeutics called antibody oligonucleotide conjugates (AOCs).
RNA
US$28.46
7D
-4.7%
1Y
-26.6%
GEO Group
Market Cap: US$3.3b
Owns, leases, operates, and manages secure facilities, processing centers, and community-based reentry facilities in the United States, Australia, the United Kingdom, and South Africa.
GEO
US$24.49
7D
5.2%
1Y
60.2%
Freshpet
Market Cap: US$3.3b
Manufactures, distributes, and markets natural fresh meals and treats for dogs and cats in the United States, Canada, and Europe.
FRPT
US$71.28
7D
-1.3%
1Y
-46.1%
Braze
Market Cap: US$3.1b
Operates a customer engagement platform that provides interactions between consumers and brands worldwide.
BRZE
US$28.17
7D
5.2%
1Y
-28.6%